A ceremony was held to mark the signing of an agreement between China Resources Group (CRG) and Charoen Pokphand Group (CP Group) to jointly launch the Life Sciences Fund on January 28, 2019. The Fund will be directed to innovative health-related technological products or services, including diagnosis, devices, therapies, medicine and technology, combined devices, and data-assisted systems, etc. Taking advantage of the shareholders’ strengths in pharmaceutical and medical fields, the Fund aims to bring in more cutting-edge products and technologies from around the world and help China’s life science achievements go global.

After giving a brief introduction to CRG’s innovations in the field of life sciences, CRG Chairman Fu Yuning said that the life sciences industry is highly risky and involves huge investment, but it is closely related to people’s needs for a better life, so CRG will keep up its investment in this field. CP’s standing for intellectual capital as well as the joint efforts of it and CRG are sure to drive the development of the life sciences industry and come to a successful end.

CP’s Overseas Finance President He Pingxian talked about the Group’s investment objectives as well as the investments it has made in Greater China Region. He also praised the efforts of both teams in preparing for the Fund. Committed to the welfare of all mankind in identical beliefs, CP and CRG are bound to make a difference in biotechnology, life sciences, medical health and other fields through concerted efforts.

Mr. Li Xiaojia, President of the Hong Kong Stock Exchange Group, Mr. Yang Xiaoping, CP’S Senior Vice Chairman, Ms. Fanny Law Fan Chiu-fun, External Director of CRG, relevant executives of the CP Group, and heads of CRG’s Strategy Department, General Office and China Resources Capital as well as several financial institutions and life science companies attended the signing ceremony.